Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings
Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.